# Acme United Corp: overview ACU · NYSE · CIK 2098 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/acu.md) · [Financials](/companies/acu/financials.md) · [Filings](/companies/acu/filings.md) · [Insiders](/companies/acu/insiders.md) Latest reported revenue: [$62.7m](/filings/0001193125-26-338211.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-338211). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [48.2](/filings/0001193125-25-269422.md) | [45.9 d](/filings/0001193125-26-102079.md) | [46.0](/filings/0001193125-26-209010.md) | [54.0](/filings/0001193125-26-338211.md) | [49.1](/filings/0001193125-25-269422.md) | [47.5 d](/filings/0001193125-26-102079.md) | [52.3](/filings/0001193125-26-209010.md) | [62.7](/filings/0001193125-26-338211.md) | | Gross margin | % | [38.5%](/filings/0001193125-25-269422.md) | [38.7% d](/filings/0001193125-26-102079.md) | [39.0%](/filings/0001193125-26-209010.md) | [41.0%](/filings/0001193125-26-338211.md) | [39.1%](/filings/0001193125-25-269422.md) | [38.2% d](/filings/0001193125-26-102079.md) | [39.7%](/filings/0001193125-26-209010.md) | [42.6%](/filings/0001193125-26-338211.md) | | Operating margin | % | [6.1%](/filings/0001193125-25-269422.md) | [5.0% d](/filings/0001193125-26-102079.md) | [5.3%](/filings/0001193125-26-209010.md) | [11.8%](/filings/0001193125-26-338211.md) | [6.1%](/filings/0001193125-25-269422.md) | [6.1% d](/filings/0001193125-26-102079.md) | [3.3%](/filings/0001193125-26-209010.md) | [10.9%](/filings/0001193125-26-338211.md) | | Net margin | % | [4.6%](/filings/0001193125-25-269422.md) | [3.7% d](/filings/0001193125-26-102079.md) | [3.6%](/filings/0001193125-26-209010.md) | [8.8%](/filings/0001193125-26-338211.md) | [3.9%](/filings/0001193125-25-269422.md) | [3.9% d](/filings/0001193125-26-102079.md) | [1.9%](/filings/0001193125-26-209010.md) | [8.1%](/filings/0001193125-26-338211.md) | | Diluted EPS | $ per share | [0.54](/filings/0001193125-25-269422.md) | not reported | [0.41](/filings/0001193125-26-209010.md) | [1.16](/filings/0001193125-26-338211.md) | [0.46](/filings/0001193125-25-269422.md) | not reported | [0.24](/filings/0001193125-26-209010.md) | [1.22](/filings/0001193125-26-338211.md) | | Free cash flow | $m | [7.5 d](/filings/0001193125-25-269422.md) | [4.7 d](/filings/0001193125-26-102079.md) | [(4.7)](/filings/0001193125-26-209010.md) | [4.7 d](/filings/0001193125-26-338211.md) | [0.3 d](/filings/0001193125-25-269422.md) | [7.3 d](/filings/0001193125-26-102079.md) | [(4.1)](/filings/0001193125-26-209010.md) | [12.1 d](/filings/0001193125-26-338211.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [182](/filings/0001564590-23-003422.md) | [194](/filings/0000950170-24-027907.md) | [192](/filings/0000950170-25-034843.md) | [194](/filings/0001193125-26-102079.md) | [197](/filings/0001193125-26-102079.md) | | Gross margin | % | [35.6%](/filings/0001564590-23-003422.md) | [32.8%](/filings/0000950170-24-027907.md) | [37.7%](/filings/0000950170-25-034843.md) | [39.3%](/filings/0001193125-26-102079.md) | [39.4%](/filings/0001193125-26-102079.md) | | Operating margin | % | [7.0%](/filings/0001564590-23-003422.md) | [3.2%](/filings/0000950170-24-027907.md) | [6.9%](/filings/0000950170-25-034843.md) | [7.3%](/filings/0001193125-26-102079.md) | [7.5%](/filings/0001193125-26-102079.md) | | Net margin | % | [7.5%](/filings/0001564590-23-003422.md) | [1.6%](/filings/0000950170-24-027907.md) | [9.3%](/filings/0000950170-25-034843.md) | [5.2%](/filings/0001193125-26-102079.md) | [5.2%](/filings/0001193125-26-102079.md) | | Diluted EPS | $ per share | [3.45](/filings/0001564590-23-003422.md) | [0.82](/filings/0000950170-24-027907.md) | [4.86](/filings/0000950170-25-034843.md) | [2.45](/filings/0001193125-26-102079.md) | [2.49](/filings/0001193125-26-102079.md) | | Free cash flow | $m | [(1.2)](/filings/0001564590-23-003422.md) | [(1.4)](/filings/0000950170-24-027907.md) | [24.2](/filings/0000950170-25-034843.md) | [4.8](/filings/0001193125-26-102079.md) | [7.6](/filings/0001193125-26-102079.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/acu/insiders.md) | Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing | | --- | --- | --- | --- | ---: | ---: | ---: | --- | | 2026-10-09 | [Holden Richmond Y JR](/insiders/1213240.md) | Director | Sale (S) | 341 | $62.01 | $21.1k | [Form 4](/filings/0001193125-26-428985.md) | ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CAPITAL MANAGEMENT CORP /VA](/funds/1074273.md) | 2026-06-30 | $22.6m | 474,147 | | Reduced −26,820 | | [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $18.2m | 380,643 | | Unchanged | | [North Star Investment Management Corp.](/funds/1342857.md) | 2026-06-30 | $11.8m | 247,653 | | Reduced −4,986 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $8.6m | 179,760 | | Added +14,070 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $8.5m | 177,131 | | Added +5,554 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $7.0m | 146,403 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.9m | 145,118 | | Added +4,126 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $5.2m | 109,607 | | Reduced −6,951 | | [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $5.2m | 108,195 | | Reduced −1,214 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.0m | 83,814 | | Added +6,913 | ## Recent filings [All 791 filings](/companies/acu/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 09:18 ET | [8-K](/filings/0001193125-26-432999.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-432999 | | 2026-08-06 | 16:30 ET | [10-Q](/filings/0001193125-26-338211.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338211 | | 2026-07-23 | 08:08 ET | [8-K](/filings/0001193125-26-313374.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-313374 | | 2026-07-21 | 16:15 ET | [8-K](/filings/0001193125-26-310329.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-310329 | | 2026-05-06 | 16:15 ET | [10-Q](/filings/0001193125-26-209010.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209010 | | 2026-04-28 | 16:30 ET | [8-K](/filings/0001193125-26-187237.md) | 5.07 Shareholder vote results | 0001193125-26-187237 | | 2026-04-23 | 09:00 ET | [8-K](/filings/0001193125-26-172010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-172010 | | 2026-03-27 | 17:18 ET | [DEF 14A](/filings/0001193125-26-129439.md) | Proxy statement, period 2026-04-27 | 0001193125-26-129439 | | 2026-03-11 | 16:00 ET | [10-K](/filings/0001193125-26-102079.md) | Annual report, period 2025-12-31 | 0001193125-26-102079 | | 2026-02-26 | 10:27 ET | [8-K](/filings/0001193125-26-074247.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-074247 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-102079.md), filed Mar 11, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/f5199114-ff7b-433e-8edc-55dc73cd5813) ## About the filer - CIK: 2098 - Tickers: ACU - Exchange: NYSE - SIC code: 3420 Cutlery, Handtools & General Hardware - State of incorporation: CT - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:40 ET. No prices; not investment advice.